Portfolio company
TTOP
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
TTOP develops modular microphysiological platforms and culture modules for researchers to replicate human biology and conduct predictive in-vitro drug testing and tissue modelling.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Tissue Dynamics
This company develops sensor-integrated organ-on-chip platforms for pharmaceutical, nutraceutical and cosmetic customers to accelerate drug discovery and safety testing.
Vitroscope
The company develops automated perfusion platforms for cell and tissue research, providing microenvironment control systems to researchers and pharmaceutical laboratories.
Hooke Bio
This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.
Finnadvance
This company develops microfluidic organ-on-chip platforms for pharmaceutical and academic researchers to perform drug testing and mimic human organ functions.
Polyphron
Polyphron manufactures donor-diverse human tissues and develops AI simulation models to help biotechnology and pharmaceutical companies test drug candidates and biological predictions.
Cellbox Labs
This company develops automated organ-on-chip platforms for pharmaceutical firms to perform precise drug discovery and testing without using animal models.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
insphero
The company develops three-dimensional microtissue models and cell culture tools for pharmaceutical and biotechnology researchers to test drug safety and efficacy.
